Articles, App Notes, Case Studies, & White Papers

31. Answering Questions About The Global Vaccine Clinical Trial Landscape 12/5/2024

    The global vaccine trial landscape is advancing rapidly, driven by new technologies and evolving regulations. Explore the answers to six questions about this rapidly evolving field.

32. Time: A Crucial Factor In Therapeutics Development 4/21/2025

    Accelerate your mRNA development and strengthen your response to emerging health threats with next-generation, cell-free DNA template solutions designed for speed, quality, and reliability.

33. Overview Of Bladder Cancer: Global Clinical Trials Landscape 11/15/2024

    Advances in immunotherapy, targeted drugs, and clinical trials are improving outcomes for bladder cancer patients, addressing regional disparities and accessibility challenges worldwide.

34. Choosing The Best mRNA Manufacturing Strategy 12/12/2025

    Choosing the right mRNA manufacturing model can define your success. Learn how to weigh control, cost, and flexibility to build a strategy that supports innovation and long-term growth.

35. A Risk-Based Approach To Validation Studies For Sterilizing-Grade Filtration And Single-Use Systems 10/3/2024

    One way to address risk related to product quality is by implementing a Question-Based Review approach. Read on to learn about this approach and its advantages.

36. Solid Tumors: Asia Pacific Clinical Trial Landscape 9/29/2022

    Read more about how the large population and lower volume of studies decreases competing trial risk in this region with a great need for novel drug therapies for solid tumors in Asian patients

37. 5 Steps To Design A Microbiological Performance Qualification For Facilities 4/21/2025

    Explore five steps to design an EMPQ for sterile manufacturing: classification, protocol drafting, cleaning evaluation, disinfectant efficacy testing, and continuous improvement.

38. Regulatory Guidance On GMP Software 2/23/2022

    Explore the regulatory requirements for software in a biopharmaceutical GxP environment and why software is invaluable for creating an audit trail, reporting, and automating regulatory-related tasks.

39. The Cell & Gene Therapy Clinical Trials Global Landscape 5/9/2023

    Gain valuable insights into the current state of cell and gene therapy clinical trials and the opportunities and challenges in this rapidly evolving field.

40. New Perspectives On Accelerating Genetic Nanomedicines Through The Regulatory Pathway 3/1/2024

    Discover how regulatory bodies are adopting a risk-based approach to address the unique challenges of genetic nanomedicines, and stakeholder engagement is essential.